Use of Mefenamic Acid as a Supportive Treatment of COVID-19: A Repurposing Drug

Dr. R. P. Pareek

Abstract: COVID-19 (coronavirus disease 2019) is a Pandemic of concern, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As of now, there is no known effective pharmaceutical or other medicine available for cure or prevention of COVID-19. In this review, based on the current understanding of the disease and the structure of novel Coronavirus SARS-CoV-2, SARS-CoV and other human viruses, I have identified Mefenamic Acid, an anti-inflammatory medicine, of having some role as an anti-viral medicine also. It can be used along with different anti-viral drugs being tried for the treatment of Covid 19. Since it is also an anti-pyretic, its main role may be of bringing down the fever but its action as an anti-viral, as a supportive medicine can very useful. Clincal trials with this concept in mind can be started immediately at the Centre dedicated for treatment of Covid 19.

Keywords: COVID-19, SARS-CoV-2, Mefenamic acid, serine protease inhibitor, NLRP3 inflammasome

How to Cite?: Dr. R. P. Pareek, "Use of Mefenamic Acid as a Supportive Treatment of COVID-19: A Repurposing Drug", Volume 9 Issue 6, June 2020, International Journal of Science and Research (IJSR), Pages: 69-73, https://www.ijsr.net/getabstract.php?paperid=SR20530150407, DOI: https://dx.doi.org/10.21275/SR20530150407

Download Citation: APA | MLA | BibTeX | EndNote | RefMan